Here, we report NucRFAP-2, a nuclear-targeted, activity-based sensing ratiometric probe for formaldehyde (FA) detection, and apply it to identify new, human disease-relevant epigenetic contributors to the nuclear FA pool.
No takes yet. Share an insight, caveat, or question.
Tenney et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: